Cannabinol - 20 mg/ml in methanol
CAS : 521-35-7
Ref. 3D-FC19669
5mg | 136,00 € | ||
10mg | 188,00 € | ||
25mg | 352,00 € | ||
50mg | 548,00 € | ||
100mg | 821,00 € |
Informations sur le produit
- 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol3-Amyl-1-hydroxy-6,6 ,9-trimethyl-6H-dibenzo[b,d]pyran6,6,9-Trimethyl-3-pentyl-6H -dibenzo[b ,d]pyran-1-olCBN
- 3-Amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
- 6,6,9-Trimethyl-3-Penyl-6H-Dibenzo(B,D)Puran-1-Ol
- 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
- 6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol
- 6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
- Cannabinol
- NSC 134455
- cannabinol crystalline--dea*schedule I item
Cannabinol is a moderately psychoactive phytocannabinoid that acts as a partial agonist at the CB1 and the CB2 receptors, preferentially binding to the latter (Ki = 1130 nM and 301 nM, respectively) (Yea, 2000). In vitro binding to the CB2 receptor was demonstrated to trigger apoptotic pathways, blocking the release of cytokines in murine T lymphocytes (Munson, 1975). In vivo animal experimental models showed reduction in primary tumor size and an increase in mean survival time upon treatment with cannabinol in Lewis lung adenocarcinoma (Munson, 1975). Cannabinol was also shown to activate peripheral neuronal receptors and promote vasorelaxation, unlike other synthetic cannabinoid receptor agonists, via a CB receptor-independent mechanism.
Propriétés chimiques
Question d’ordre technique sur : 3D-FC19669 Cannabinol - 20 mg/ml in methanol
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages